Monthly Archives: July 2010

WASHINGTON, July 30 (UPI) — The Food and Drug Administration has given approval to proceed with the world’s first human clinical trial of a human embryonic stem cell-based therapy. Food and Drug Administration – Stem cell – Clinical trial – … Continue reading →

A trial could offer the first glimpse of a technology that may hold vast medical promise but also is embroiled in controversy.

A therapy for acute spinal cord injuries developed by a UC Irvine scientist will become the world’s first clinical trial of a treatment using human embryonic stem cells. Geron Corp. of Menlo Park announced Friday that the U.S. Food and … Continue reading →

Geron will begin tests of its therapy for spinal cord injury. Advanced Cell Technology hopes to follow with a stem cell treatment for blindness. The Food and Drug Administration has cleared Geron, a stem cell company based in Menlo Park, … Continue reading →

Geron Corp. said it was cleared by U.S. regulators to proceed with the first human test of an embryonic stem-cell therapy, aimed at patients with spinal-cord injuries. The shares rose 17 percent.

Geron Corp. said U.S. regulators cleared the company to proceed with the first medical trial of embryonic stem-cell treatment in patients with spinal-cord injuries. The shares rose as much as 16 percent.

WASHINGTON The FDA’s blessing Friday of the world’s first clinical trial of a human embryonic stem cell (hESC) therapy has not only launched what may be “the dawn of a new era” for medical treatment, but if successful, the therapies … Continue reading →

Geron says FDA will allow embryonic stem cell study; safety concerns caused 11-month delay Stem cell – Embryonic stem cell – Biotechnology – Spinal cord injury – Geron Corporation

Geron Corp. said it has been cleared by regulators to proceed with the first human test of an embryonic stem cell therapy, designed for patients with spinal-cord injuries. The shares rose as much as 16 percent. The Food and Drug … Continue reading →